ELISA kit for detecting human BP180 IgG antibody and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A BP180 and kit technology, applied in the field of medicine, can solve the problem of not meeting the diagnostic needs of clinical BP and anti-BP180MMP, and achieve the effect of cost increase and cost saving
Pending Publication Date: 2022-03-25
李小光
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Therefore, the current commercial BP180 IgG antibody detection kit that recognizes BP180 NC16a obviously cannot meet the diagnostic needs of clinical BP and anti-BP180 MMP
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0041] Embodiment 1 is used to detect the preparation of the ELISA kit of BP180 IgG antibody
[0042] 1. Composition:
[0043] ELISA kit includes:
[0044] (1) BP180 microwell strip (48 wells)
[0045] (2) 0 U / ml standard serum 1 (reaction buffer solution containing 0.05% sodium azide w / v, 1.5ml)
[0046] (3) 100U / ml standard serum 2 (serum from patients with positive BP180 IgG autoantibody diluted in reaction buffer containing 0.05% w / v sodium azide, 1.5ml)
[0053] (1) The coated material includes 29 BP180...
Embodiment 2
[0079] The performance index detection of embodiment 2 kit
[0080] (1) Sample source
[0081] Bullous pemphigoid, mucosal pemphigoid (BP180 type), mucosal pemphigoid (anti-laminin 332) and pemphigus vulgaris were collected 50 times each, part of which came from the Department of Dermatology, Kurume University, Japan. Donated by Professor Takashi Hashimoto (collected from patients in Japan and all over the world), the other part comes from the serum of the remaining patients after the serological diagnosis of skin autoimmune blister disease provided by the dermatology department of a tertiary hospital in China or a dermatology hospital . 300 parts of normal human serum were the remaining serum from normal physical examination in the hospital.
[0082] Serum was diluted 1:50.
[0083] (2) Specificity and sensitivity
[0084] 50 parts of bullous pemphigoid, mucosal pemphigoid (BP180 type) patient sera were detected using commercialized ELISA kit (MBL company) and the ELISA k...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses an ELISA (enzyme-linked immuno sorbent assay) kit for detecting a human BP180 IgG (immunoglobulin G) antibody and application of the ELISA kit. The kit contains a BP180 microporous band, and the BP180 microporous band is respectively coated with polypeptides as shown in SEQ ID NO. 1-29 or a mixture of the polypeptides as shown in SEQ ID NO. 1-29. Preferably, the kit also contains standard serum 1 and 2, an enzyme-labeled antibody, a diluent, a reaction buffer solution, a cleaning buffer solution, an enzyme matrix solution and a stop solution. According to the invention, a plurality of antigen polypeptides are used for replacing a long-fragment complete protein as a coating protein of ELISA, so that a large amount of cost is saved while antigen epitopes recognized by an antibody are fully guaranteed, and compared with NC16a recombinant protein, the sensitivity is higher. According to the invention, the human BP180 IgG antibody is detected by using an ELISA method, and compared with an existing immunoblotting method, the ELISA method is easier to be applied to clinical diagnosis of bullous pemphigus and BP180 type mucous membrane pemphigus.
Description
technical field [0001] The invention relates to an ELISA kit and its application, in particular to an ELISA kit for detecting human BP180 IgG antibody and its application. The invention belongs to the technical field of medicine. Background technique [0002] Bullous pemphigoid (BP) and BP180-type mucous membrane pemphigoid (anti-BP180-type MMP) both belong to human skin autoimmune blistering diseases, which mainly affect the skin of the elderly. Immune vesicular disease. The similarity between the two is that both need to detect anti-BP180 IgG autoantibodies to make a diagnosis. The difference is mainly in the clinical features. Patients with bullous pemphigoid only have skin lesions, while BP180 mucosal pemphigoid can Presents as damage to the skin and mucous membranes, or only to the mucous membranes. [0003] Existing methods for detecting IgG autoantibodies to human BP180 mainly include immunoblotting and ELISA. Western blotting mainly uses epidermal extracts or rec...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more